Topical Review Section Editors: Wolf-Dieter Heiss, MD, and Chelsea S. Kidwell, MD

Arterial Spin–Labeled Perfusion Imaging in Acute Ischemic Stroke Greg Zaharchuk, MD, PhD

A

(Alsop et al, in press, 2014) suggests the use of pseudocontinuous labeling, with a labeling time (TL) of 1500 to 1800 ms; longer TL (between 3000 and 4000 ms) is more efficient from an SNR per-unit time perspective, although as of yet, there is little clinical experience with such sequences. The requirements for the inflow segment are to allow time (called the postlabel delay [PLD]) for the labeled water to traverse the proximal vasculature, reach the capillary bed, and exchange with tissue water. This same white paper suggests a PLD of 2000 ms as a default for adult clinical patients (Alsop et al, in press, 2014). Although longer PLD would be advantageous in acute stroke to account properly for late arriving or collateral flow, this incurs an SNR penalty because the magnetic label is decaying during this period. In our experience, a TL of 1500 ms and a PLD of 2000 ms are adequate for clinical triage of the vast majority of patients with acute ischemic stroke and have the advantage that one does not need to alter the protocol for patients with acute stroke patients specifically. Furthermore, this TL–PLD combination can highlight late-arriving collateral flow because the label will still be present in the feeding arteries, an effect known as arterial transit artifact2 (ATA; Figure 1). However, if one knows that a patient is presenting for an acute stroke workup and is more interested in quantitative CBF rather than the collateral visualization, it might make sense to alter the routine protocol and perform the ASL study with a long label/long delay paradigm (eg, TL/PLD 3000/3000 ms). Another promising approach is the use of multidelay ASL, in which a fixed TL is coupled with images collected at multiple PLDs,3–5 allowing for dynamic assessment of inflow; with proper kinetic modeling, it may be possible to obtain a more accurate CBF assessment, as well as make an independent measurement of arrival time, which may itself be a valuable measurement. The goal of the imaging segment is to acquire a high-SNR, high-resolution image of the tissue with minimal distortions and artifacts. Historically, 2-dimensional (2D) echo-planar single-shot imaging was used for this purpose. However, although multishot echo-planar imaging approaches can mitigate some of the distortion problems at the expense of SNR, increased SNR has been demonstrated using 3D methods, particularly 3D fast spin-echo imaging using a stack-of-spirals

rterial spin labeling (ASL) is an MRI method that enables the measurement of tissue perfusion without the use of exogenous contrast agents by magnetically tagging the water in inflowing blood.1 It was first proposed in the early 1990s and, since then, has been primarily a research technique. Recent advances in pulse sequence design and the more widespread availability of higher-field (ie, 3T) MRI scanners, both of which improve the signal-to-noise ratio (SNR) of the technique dramatically, have resulted in increased adoption in the clinical neuroimaging community. All 3 major MRI vendors now support some form of ASL imaging as a product. At first glance, it would seem that ASL is a particularly ill-suited technique to image acute ischemic stroke. The ASL signal is roughly proportional to cerebral blood flow (CBF), which is markedly decreased in the core of large vessel ischemic stroke. Furthermore, what CBF does remain is often supplied by circuitous collateral routes, leading to longer arterial arrival times. Because the magnetic label decays with the blood T1 (typically between 1.2 and 1.8 s at clinical magnetic field strengths), the ASL signal will not accurately represent CBF in these regions under normal operating conditions. Finally, there is extensive research and clinical experience with another MRI perfusion method, bolus dynamic susceptibility contrast (DSC), which can be acquired relatively rapidly in the acute setting. Remarkably, despite these limitations, an increasing number of studies are showing that there is a place for ASL in the workup of acute ischemic stroke with MRI. In this review, I highlight recommended imaging parameters for ASL stroke studies, discuss typical image quality and artifacts, review the recent clinical literature of ASL in stroke (particularly vis a vis the more routine and accepted method of DSC), mention limitations, and finally discuss the future of this promising noncontrast stroke perfusion technique.

ASL Technique: Background, Implementations, and Recommendations for Acute Stroke ASL sequences differ from one another based on alterations of the tagging, inflow, and the readout segments of the sequence. The goal of the tagging segment is to label the inflowing blood water; ideally, the goal is to label as much blood as possible as near to the brain as possible. A recent consensus white paper

Received December 26, 2013; accepted January 24, 2014. From the Department of Radiology, Stanford University and Stanford University Medical Center, Stanford, CA. Correspondence to Greg Zaharchuk, MD, PhD, 1201 Welch Rd, Mailcode 5488, Stanford, CA 94305–5488. E-mail [email protected] (Stroke. 2014;45:1202-1207.) © 2014 American Heart Association, Inc. Stroke is available at http://stroke.ahajournals.org

DOI: 10.1161/STROKEAHA.113.003612

1202

Zaharchuk   ASL in Acute Ischemic Stroke    1203

Figure 1. Images of patients with acute stroke with (top) good and (bottom) poor collaterals, acquired at 3T, after coregistration and normalization. Note the serpiginous high signal on the arterial spin labeling (ASL) maps (arrows) in the affected region in the patient with good collaterals, which is absent in the patient with poor collaterals. Dynamic susceptibility contrast–based hemodynamic maps demonstrate near-normal cerebral blood flow (CBF) in the affected regions with good collaterals, despite the presence of Tmax delays, suggesting critically hypoperfused tissue. CAD indicates combined ASL and dynamic susceptibility contrast, a method of obtaining quantitative CBF and CBV; CBV, cerebral blood volume; DWI, diffusion-weighted imaging; pcASL, pseudocontinuous arterial spin labeling; and Tmax, normalized time to the maximum of the residue function.

approach,6 which is recommended by the previously described white paper. This also has the advantage of significantly reduced distortions, enabling imaging of challenging regions such as the inferior frontal and temporal lobes as well as the posterior fossa.

Typical Imaging Findings and Artifacts in Acute Stroke As expected, patients with acute ischemic stroke typically present with a perfusion deficit (ie, low-to-absent ASL CBF signal) in the affected region (Figure 1). Depending on the precise parameters for TL and PLD, ATA may be visible at

the periphery of the stroke, representing labeled blood that has not yet reached the capillary bed at the time of imaging. Reperfusion of acute stroke lesions is also common, either spontaneously or after successful intravenous or endovascular treatment. In these cases, increased CBF is often identified within the affected tissue (Figure 2). This phenomenon is known as luxury perfusion. In most cases, it is a good prognostic factor in patients undergoing stroke MRI, correlating with lack of subsequent infarct growth.7 It is occasionally difficult to distinguish between high ASL signal related to delayed arrival time and that related to parenchymal hyperperfusion. One helpful way to tell is if you identify low ASL

1204  Stroke  April 2014

Figure 2. A 61-year-old man with new left-sided weakness, imaged at 1.5T. There is increased conspicuity of hyperperfusion with arterial spin labeling (ASL) compared with dynamic susceptibility contrast (DSC) imaging. Subtle increased relative cerebral blood flow (CBF) and reduced Tmax are noted in the same region on the DSC images. Multiple studies have shown that the presence of hyperperfusion after acute stroke is a good prognostic feature, with smaller infarct growth and better clinical outcomes. DWI indicates diffusion-weighted imaging; rCBF, relative CBF; and Tmax, normalized time to the maximum of the residue function.

signal in the territory distal to the brighter signal, it is probably ATA; if not, it is probably hyperperfusion.8 Another artifact to be aware of is overall slow flow to the brain, which is sometimes seen in older patients or those with poor cardiac output. In this case, using standard ASL parameters, ASL signal is only seen in the large arterial structures. This is an extreme case of ATA, and it makes interpretation of focal CBF deficits impossible. This has been called the ASL borderzone sign and is more prevalent at 1.5T.9 In these cases, if there is time to repeat the study, often, ASL acquisition with longer labeling and longer PLD can mitigate this problem and allow better visualization of the focal perfusion deficit.

Clinical ASL Stroke Studies The first study of ASL in stroke was performed by Siewert et al,10 demonstrating that ASL was capable of detecting perfusion alterations in patients with stroke, and that these were largely concordant with gadolinium-based methods. In 2000, Chalela et al performed the first significant clinical study on the use of ASL in acute stroke.11 They demonstrated the feasibility of using ASL in this patient population, found the expected CBF decreases in the affected regions, and showed that CBF deficits correlated with the National Institutes of Health Stroke Scale. They also identified the frequent presence of ATA and noted that it was related to better clinical outcomes, presaging future approaches that use ASL to map collateral blood flow. During the ensuing decade, fewer studies were performed, mainly because of the challenges of implementing the available ASL sequences on clinical scanners. However, there has been a resurgence in the use of ASL generally, and in stroke specifically, in the current decade. This has been driven in part by better ASL sequence methods, as discussed above, some of which became widely available as vendor works-in-progress, and by the increased availability of 3T imaging. In 2012, 3 large studies12–14 were published comparing ASL perfusion with DSC, a gadolinium-based technique that was the standard for measuring cerebral perfusion. These studies had largely concordant findings, suggesting that ASL could be used in place of DSC without any change in interpretation or subsequent clinical

management. To understand them, it is important to understand the landscape of acute stroke MRI at the time. The dominant paradigm in stroke MRI is the diffusion-perfusion mismatch with a similar mismatch approach also used with computed tomographic perfusion.15,16 Although a somewhat simplistic framework,17 the basic idea is that regions with reduced diffusion, typically below a certain critical threshold, represent irreversibly infarcted tissue. Regions with critically low perfusion but normal diffusion represent tissue that is functionally compromised but not yet beyond the point of no return, provided that the tissue can be reperfused in an efficacious manner. This diffusion-negative, perfusion-positive tissue has been termed the ischemic penumbra and is thought to be the target of any acute interventions. Although measuring the diffusion lesion is relatively straightforward, the problem is really the perfusion images that are acquired during rapid passage of the gadolinium bolus. To produce meaningful information, they require postprocessing, in which various assumptions are made, and that varies widely between different sites and scanners. Several large clinical trials have suggested that blood arrival delay (measured as the time-to-peak [TTP] of the gadolinium concentration or normalized time to the maximum of the residue function [Tmax]) can provide a reliable measure of critically hypoperfused brain tissue.18–20 Therefore, these 3 ASL stroke studies sought to compare the ASL findings with the DSC findings with regard to diffusion-perfusion mismatch stratification and to address the question of whether ASL could be substituted for DSC. This might be considered desirable because the lack of contrast would enable the use of the mismatch paradigm in patients who cannot receive gadolinium contrast. Also, because the postprocessing of ASL data is relatively simple compared with DSC, this might improve reliability and transferability between different sites and scanners. Zaharchuk et al12 showed that clinical ASL was feasible at 1.5T using a pseudocontinuous labeling method with optimized readout. DSC was considered the gold-standard perfusion method for classifying patients into clinically relevant subgroups (ie, those with a mismatch, no mismatch, or reperfusion). They found good inter-reader reliability but found that exact agreement was only seen in ≈60% of cases; this

Zaharchuk   ASL in Acute Ischemic Stroke    1205 was higher (74%) for distinguishing the key categories of mismatch versus either matched or reperfused regions. In cases in which there were discrepancies, ASL tended to overestimate the perfusion deficit, likely because of the longer arrival times of the blood in affected regions. Bokkers et al13 performed a larger study of ASL in consecutive patients with acute stroke at 3T evaluating the conspicuity of perfusion lesions using both ASL and DSC. One interesting observation they made was that ≈20% of patients in their series could not receive gadolinium because of reduced renal function, highlighting a key advantage of noncontrast ASL perfusion. In patients who could also receive DSC studies, they found that when a perfusion deficit was present on DSC, it was also seen on 82% of ASL images. The cases in which ASL was deemed normal tended to be the smaller lesions, such as small cortical and subcortical strokes. They also found that interpretable perfusion studies were achieved at similar rates with both methods, and that image quality was similar. They found that agreement between DSC and ASL for significant mismatch was 88%; this higher agreement may have been because of the use of higher field strength. Overall, their study highlighted that particularly for the large territory strokes that are the greatest source of morbidity, ASL is a reasonable alternative to DSC, and furthermore, it enabled evaluation of diffusion-perfusion mismatch in patients with contraindications to gadolinium. Finally, Wang et al14 demonstrated similar findings, focusing on consistency of ASL and DSC results as well as image quality. They found good concordance with multiple DSC biomarkers, including Tmax, mean transit time (MTT), and relative CBF. They also highlighted that ASL had particular value in visualizing hyperperfusion compared with DSC, a finding confirmed in a subsequent study by Bivard et al,7 who also showed that ASL hyperperfusion at 24 hours was associated with better clinical outcomes in acute stroke. Since these studies, other studies have looked at whether more quantitative approaches can be applied to ASL. This is important because quantitative image analysis may improve mismatch estimations compared with visual inspection. Also, ASL is inherently a quantitative technique, such as that absolute measures of CBF may provide more information than relative measures. Bivard et al21 showed that the best relative threshold for ASL CBF maps to identify critical hypoperfusion was ≈40% of mean contralateral CBF. Using this threshold, they showed high correlation between mismatch lesion volume defined by either DSC or ASL, although again, they confirmed that ASL tended to overestimate the size of perfusion lesions because of late arriving flow. A similar study by Niibo et al,22 using a quantitative CBF threshold of 20 mL/100 g per min, found that the ASL mismatch had 100% agreement with a mismatch based on DSC mean transit time ≥10 s. Although ischemic stroke is primarily a disease of older adults, it does occur in children; because of its rarity, making the correct diagnosis can be challenging. ASL is a promising technique in this patient population, given their overall higher baseline CBF and shorter arterial arrival times. Chen et al23 describe their initial experience evaluating pediatric ischemic stroke with ASL, demonstrating good concordance of the location and character of the perfusion deficits with

clinical and diffusion-weighted imaging findings. Particularly interesting is the possibility that ASL might be sensitive to preclinical ischemic episodes in children with mitochondrial disease. Ikawa et al24 showed an abnormally high ASL signal in a patient with myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome several months before the clinical appearance of a diffusion-positive stroke-like episode, suggesting it could be used for management. More recently, small studies have also been performed in perinatal stroke,25,26 a challenging group of patients because of their small size, motion, and longer arterial arrival times. These studies have shown that ASL is feasible and can visualize hypoperfusion and hyperperfusion lesions. Perinatal ASL avoids the difficulties of DSC in this patient group but comes with its own set of challenges, given many factors that affect ASL CBF measurements, including effects of arrival time, hematocrit, and labeling efficiency.

Limitations of ASL in Acute Stroke Despite the enthusiasm of the research community regarding ASL in acute stroke, several important limitations must be mentioned. Although it has many attractive properties, ASL is a lower SNR technique than DSC. There are several distinct modes of failure unique to ASL. One of these is an artifact that presents as overall reduced CBF to a vascular territory that is not attributable to true reduced flow but rather to reduced labeling efficiency of the water in a specific artery at the labeling plane in the neck27; this artifact is specific to continuous and pseudocontinuous ASL and, although it occurs rarely, it can create confusion in acute stroke given that territorial infarcts might be expected to present with identical findings. Finally, motion artifacts affect ASL as they do all MRI sequences. More recent ASL sequences are background suppressed, and this affords a certain degree of insensitivity to motion. Several methods exist to address motion artifacts in ASL. One is to simply remove the raw images that have motion before signal averaging28; this is feasible but ultimately reduces the SNR of the final perfusion images. Another approach is the use of prospective motion correction,29 in which navigator images track the head in real time and are used to follow the head motion during image collection.

Future of Acute Stroke ASL Imaging What will be the role of ASL in acute stroke in the next several years? Given the flexibility of the technique, it is hard to predict, but some areas of active research at the moment are the use of ASL to assess collateral blood flow and obtain truly quantitative CBF in patients with stroke. Several recent studies focusing on the mismatch hypothesis have suggested that different imaging profiles can be identified that predict lesion growth and patient outcome after early reperfusion in acute stroke.18–20 However, the recent failure of several high-profile clinical stroke trials makes it clear that better patient selection for endovascular therapy is critical.30–32 An increasing number of studies suggest that collateral flow may play a central role in sustaining tissue viability and reducing complications.33–36 ASL has features that make it an ideal MRI-based modality to assess collaterals: it is noninvasive

1206  Stroke  April 2014 and combines features of perfusion and angiography, based on its sensitivity to delayed arterial arrival. Recently, several groups have evaluated the predictive ability of ASL to identify the regional pattern of collaterals.37–39 Chng et al37 and Wu et al39 demonstrated good agreement of pulsed ASL sequences in patients with arterial steno-occlusive disease, whereas Zaharchuk et al38 showed similar findings with pseudocontinuous ASL in patients with Moyamoya disease. Figure 1 shows an example of the difference between good and poor collaterals on ASL imaging in 2 patients with acute ischemic stroke. Ultimately, the most important factor for tissue survival is probably not the presence of collaterals, per se, but rather how effective they are at delivering CBF to the ischemic territory. Although ASL can measure quantitative CBF relatively easily in normal subjects and in those with mild arterial arrival delays, quantification is challenging in patients with stroke. Several approaches show promise in this regard. The first is multidelay ASL, which acquires images at multiple PLDs, to disentangle the effects of CBF and arrival time; unfortunately, this comes at the price of reduced image quality, although newer methods, such as Hadamard encoding,40 reduce the associated penalties. Another is the use of velocity-selective ASL (VS-ASL), a method that performs the labeling step in the imaged voxel itself, thereby reducing transit time effects.41,42 VS-ASL has yet to be applied to an acute stroke study and again has limitations in terms of SNR.

Conclusions Despite the inherent challenges of ASL in cerebrovascular disease, it is beginning to enter the mainstream of clinical MRI stroke studies, showing many similarities to DSC perfusion imaging. Perhaps the most interesting cases are those in which differences between the techniques are seen, either because of collateral flow or reperfusion, that suggest that ASL may have additive value in patients with stroke. Further sequence development is required and is ongoing to increase imaging speed and image quality.

Sources of Funding This work was supported in part by funding from the National Institutes of Health (R01-NS066506, R01-NS047607).

Disclosures Dr Zaharchuk receives research funding from GE Healthcare.

References 1. Detre JA, Leigh JS, Williams DS, Koretsky AP. Perfusion imaging. Magn Reson Med. 1992;23:37–45. 2. Detre JA, Samuels OB, Alsop DC, Gonzalez-At JB, Kasner SE, Raps EC. Noninvasive magnetic resonance imaging evaluation of cerebral blood flow with acetazolamide challenge in patients with cerebrovascular stenosis. J Magn Reson Imaging. 1999;10:870–875. 3. Hendrikse J, van Osch MJ, Rutgers DR, Bakker CJ, Kappelle LJ, Golay X, et al. Internal carotid artery occlusion assessed at pulsed arterial spin-labeling perfusion MR imaging at multiple delay times. Radiology. 2004;233:899–904. 4. Petersen ET, Lim T, Golay X. Model-free arterial spin labeling quantification approach for perfusion MRI. Magn Reson Med. 2006;55:219–232. 5. Wang DJ, Alger JR, Qiao JX, Gunther M, Pope WB, Saver JL, et al; UCLA Stroke Investigators. Multi-delay multi-parametric arterial spin-labeled perfusion MRI in acute ischemic stroke - Comparison with dynamic susceptibility contrast enhanced perfusion imaging. Neuroimage Clin. 2013;3:1–7.

6. Dai W, Garcia D, de Bazelaire C, Alsop DC. Continuous flow-driven inversion for arterial spin labeling using pulsed radio frequency and gradient fields. Magn Reson Med. 2008;60:1488–1497. 7. Bivard A, Stanwell P, Levi C, Parsons M. Arterial spin labeling identifies tissue salvage and good clinical recovery after acute ischemic stroke. J Neuroimaging. 2013;23:391–396. 8. Zaharchuk G. Arterial spin labeling for acute stroke: practical considerations. Transl Stroke Res. 2012;3:228–235. 9. Zaharchuk G, Bammer R, Straka M, Shankaranarayan A, Alsop DC, Fischbein NJ, et al. Arterial spin-label imaging in patients with normal bolus perfusion-weighted MR imaging findings: pilot identification of the borderzone sign. Radiology. 2009;252:797–807. 10. Siewert B, Bly BM, Schlaug G, Darby DG, Thangaraj V, Warach S, et al. Comparison of the BOLD- and EPISTAR-technique for functional brain imaging by using signal detection theory. Magn Reson Med. 1996;36:249–255. 11. Chalela JA, Alsop DC, Gonzalez-Atavales JB, Maldjian JA, Kasner SE, Detre JA. Magnetic resonance perfusion imaging in acute ischemic stroke using continuous arterial spin labeling. Stroke. 2000;31:680–687. 12. Zaharchuk G, El Mogy IS, Fischbein NJ, Albers GW. Comparison of arterial spin labeling and bolus perfusion-weighted imaging for detecting mismatch in acute stroke. Stroke. 2012;43:1843–1848. 13. Bokkers RP, Hernandez DA, Merino JG, Mirasol RV, van Osch MJ, Hendrikse J, et al; National Institutes of Health Stroke Natural History Investigators. Whole-brain arterial spin labeling perfusion MRI in patients with acute stroke. Stroke. 2012;43:1290–1294. 14. Wang D, Alger J, Qian J, Hou S, Fiaz R, Gunther M, et al. The value of arterial spin-labeled perfusion imaging in acute ischemic stroke – comparison with dynamic susceptibility contrast enhanced MRI. Stroke. 2012;43:1018–1024. 15. Neumann-Haefelin T, Wittsack HJ, Wenserski F, Siebler M, Seitz RJ, Mödder U, et al. Diffusion- and perfusion-weighted MRI. The DWI/PWI mismatch region in acute stroke. Stroke. 1999;30:1591–1597. 16. Kane I, Sandercock P, Wardlaw J. Magnetic resonance perfusion diffusion mismatch and thrombolysis in acute ischaemic stroke: a systematic review of the evidence to date. J Neurol Neurosurg Psychiatry. 2007;78:485–491. 17. Kidwell CS, Alger JR, Saver JL. Beyond mismatch: evolving paradigms in imaging the ischemic penumbra with multimodal magnetic resonance imaging. Stroke. 2003;34:2729–2735. 18. Albers GW, Thijs VN, Wechsler L, Kemp S, Schlaug G, Skalabrin E, et al; DEFUSE Investigators. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol. 2006;60:508–517. 19. Lansberg M, Straka M, Kemp S, Mlynash M, Wechsler L, Jovin T, et al. MRI profile and response to endovascular reperfusion after stroke (DEFUSE-2): a prospective cohort study. Lancet Neurol. 2012;11:860–867. 20. Davis SM, Donnan GA, Parsons MW, Levi C, Butcher KS, Peeters A, et al; EPITHET investigators. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol. 2008;7:299–309. 21. Bivard A, Krishnamurthy V, Stanwell P, Levi C, Spratt NJ, Davis S, et al. Arterial spin labeling versus bolus-tracking perfusion in hyperacute stroke. Stroke. 2014;45:127–133. 22. Niibo T, Ohta H, Yonenaga K, Ikushima I, Miyata S, Takeshima H. Arterial spin-labeled perfusion imaging to predict mismatch in acute ischemic stroke. Stroke. 2013;44:2601–2603. 23. Chen J, Licht DJ, Smith SE, Agner SC, Mason S, Wang S, et al. Arterial spin labeling perfusion MRI in pediatric arterial ischemic stroke: initial experiences. J Magn Reson Imaging. 2009;29:282–290. 24. Ikawa M, Yoneda M, Muramatsu T, Matsunaga A, Tsujikawa T, Yamamoto T, et al. Detection of preclinically latent hyperperfusion due to stroke-like episodes by arterial spin-labeling perfusion MRI in MELAS patients. Mitochondrion. 2013;13:676–680. 25. Wintermark P, Warfield SK. New insights in perinatal arterial ischemic stroke by assessing brain perfusion. Transl Stroke Res. 2012;3:255–262. 26. De Vis JB, Petersen ET, Kersbergen KJ, Alderliesten T, de Vries LS, van Bel F, et al. Evaluation of perinatal arterial ischemic stroke using noninvasive arterial spin labeling perfusion MRI. Pediatr Res. 2013;74:307–313. 27. Jahanian H, Noll DC, Hernandez-Garcia L. B0 field inhomogeneity considerations in pseudo-continuous arterial spin labeling (pCASL): effects on tagging efficiency and correction strategy. NMR Biomed. 2011;24:1202–1209. 28. Deibler AR, Pollock JM, Kraft RA, Tan H, Burdette JH, Maldjian JA. Arterial spin-labeling in routine clinical practice, part 1: technique and artifacts. AJNR Am J Neuroradiol. 2008;29:1228–1234.

Zaharchuk   ASL in Acute Ischemic Stroke    1207 29. Zun Z, Shankaranarayanan A, Zaharchuk G. Pseudocontinuous arterial spin labeling with prospective motion correction (pcASL-PROMO). Magn Reson Med. November 14, 2013. http://onlinelibrary.wiley.com/ journal/10.1002/(ISSN)1522–2594. Accessed December 25, 2013. 30. Kidwell CS, Jahan R, Gornbein J, Alger JR, Nenov V, Ajani Z, et al; MR RESCUE Investigators. A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med. 2013;368:914–923. 31. Broderick JP, Palesch YY, Demchuk AM, Yeatts SD, Khatri P, Hill MD, et al; Interventional Management of Stroke (IMS) III Investigators. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med. 2013;368:893–903. 32. Ciccone A, Valvassori L, Nichelatti M, Sgoifo A, Ponzio M, Sterzi R, et al; SYNTHESIS Expansion Investigators. Endovascular treatment for acute ischemic stroke. N Engl J Med. 2013;368:904–913. 33. Kucinski T, Koch C, Eckert B, Becker V, Krömer H, Heesen C, et al. Collateral circulation is an independent radiological predictor of outcome after thrombolysis in acute ischaemic stroke. Neuroradiology. 2003;45:11–18. 34. Bang OY, Saver JL, Buck BH, Alger JR, Starkman S, Ovbiagele B, et al; UCLA Collateral Investigators. Impact of collateral flow on tissue fate in acute ischaemic stroke. J Neurol Neurosurg Psychiatry. 2008;79:625–629. 35. Christoforidis GA, Mohammad Y, Avutu B, Tejada A, Slivka AP. Arteriographic demonstration of slow antegrade opacification distal to a cerebrovascular thromboembolic occlusion site as a favorable indicator for intra-arterial thrombolysis. AJNR Am J Neuroradiol. 2006;27:1528–1531.

36. Christoforidis GA, Mohammad Y, Kehagias D, Avutu B, Slivka AP. Angiographic assessment of pial collaterals as a prognostic indicator following intra-arterial thrombolysis for acute ischemic stroke. AJNR Am J Neuroradiol. 2005;26:1789–1797. 37. Chng SM, Petersen ET, Zimine I, Sitoh YY, Lim CC, Golay X. Territorial arterial spin labeling in the assessment of collateral circulation: comparison with digital subtraction angiography. Stroke. 2008;39:3248–3254. 38. Zaharchuk G, Do HM, Marks MP, Rosenberg J, Moseley ME, Steinberg GK. Arterial spin-labeling MRI can identify the presence and intensity of collateral perfusion in patients with moyamoya disease. Stroke. 2011;42:2485–2491. 39. Wu B, Wang X, Guo J, Xie S, Wong EC, Zhang J, et al. Collateral circulation imaging: MR perfusion territory arterial spin-labeling at 3T. AJNR Am J Neuroradiol. 2008;29:1855–1860. 40. Dai W, Shankaranarayanan A, Alsop DC. Volumetric measurement of perfusion and arterial transit delay using hadamard encoded continuous arterial spin labeling. Magn Reson Med. 2013;69:1014–1022. 41. Wong EC, Cronin M, Wu WC, Inglis B, Frank LR, Liu TT. Velocityselective arterial spin labeling. Magn Reson Med. 2006;55:1334–1341. 42. Qiu D, Straka M, Zun Z, Bammer R, Moseley ME, Zaharchuk G. CBF measurements using multidelay pseudocontinuous and velocity-selective arterial spin labeling in patients with long arterial transit delays: comparison with xenon CT CBF. J Magn Reson Imaging. 2012;36:110–119. Key Words: ischemia ◼ magnetic resonance imaging ◼ perfusion ◼ stroke

Arterial spin-labeled perfusion imaging in acute ischemic stroke.

Arterial spin-labeled perfusion imaging in acute ischemic stroke. - PDF Download Free
5MB Sizes 3 Downloads 3 Views